Ananth Ravi

Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Efficacy results from a randomized phase II clinical trial of one fraction of 19 Gy or two fractions of 13.5 Gy

Gerard Morton, Merrylee McGuffin, Hans T. Chung et al. · Radiotherapy and Oncology · 2020 · 129 citations

Medicine, Radiation Oncology, Urology +14

Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Early toxicity and quality-of life results from a randomized phase II clinical trial of one fraction of 19Gy or two fractions of 13.5Gy

Gerard Morton, Hans T. Chung, Merrylee McGuffin et al. · Radiotherapy and Oncology · 2016 · 88 citations

Medicine, Radiation Oncology, Urology +17

Once-weekly versus every-other-day stereotactic body radiotherapy in patients with prostate cancer (PATRIOT): A phase 2 randomized trial

Harvey Quon, Aldrich Ong, Patrick Cheung et al. · Radiotherapy and Oncology · 2018 · 75 citations

Medicine, Oncology, Radiation Oncology +12

Evaluation of a Machine-Learning Algorithm for Treatment Planning in Prostate Low-Dose-Rate Brachytherapy

Alexandru Nicolae, Gerard Morton, Hans Chung et al. · International Journal of Radiation Oncology*Biology*Physics · 2016 · 69 citations

Medicine, Computer Science, Radiation Oncology +16

Electromagnetic tracking for catheter reconstruction in ultrasound-guided high-dose-rate brachytherapy of the prostate

Shyam Bharat, Cynthia Kung, Ehsan Dehghan et al. · Brachytherapy · 2014 · 68 citations

Medicine, Radiology, Urology +16